Skip to main content
. 2023 Mar 27;6(3):e234893. doi: 10.1001/jamanetworkopen.2023.4893

Table 5. Estimate of the Marginal Effect of Plan Type on the Utilization of Diagnostic Breast Services For Patients Undergoing Subsequent Testing Relative to Plan Type With Lowest Out-of-Pocket Cost (ie, Dominantly Coinsurance)a.

Plan type and outcomes Estimate (95% CI) P value
Any subsequent breast image
Balanced −0.007 (−0.02 to 0.01) .35
Dominantly copay −0.024 (−0.04 to −0.01) <.001
Dominantly deductible −0.016 (−0.03 to −0.01) .01
Diagnostic mammogram
Balanced −0.001 (−0.01 to 0.01) .75
Dominantly copay −0.011 (−0.02 to −0.00) .02
Dominantly deductible −0.008 (−0.02 to −0.00) .04
Breast ultrasound
Balanced −0.000 (−0.01 to 0.01) .94
Dominantly copay −0.009 (−0.02 to −0.00) .03
Dominantly deductible −0.005 (−0.01 to 0.00) .23
Breast MRI
Balanced −0.005 (−0.01 to −0.00) <.001
Dominantly copay −0.006 (−0.01 to −0.00) <.001
Dominantly deductible −0.006 (−0.01 to −0.00) <.001
Breast biopsy
Balanced −0.009 (−0.02 to −0.00) .05
Dominantly copay −0.000 (−0.011 to −0.010) .94
Dominantly deductible −0.005 (−0.01 to 0.00) .29

Abbreviation: MRI, magnetic resonance imaging.

a

Estimates adjusted for patient age, race and ethnicity, prospective Charlson Comorbidity Index, and state of domicile.